• Reported GAAP EPS of $0.66 up 26.92% YoY • Reported revenue of $1.02B up 6.16% YoY • Cooper Companies raised its fiscal 2026 guidance, now expecting total revenue of $4.31B with 4.5% to 5.5% organic growth, and non-GAAP diluted EPS of $4.58 - $4.66. Free cash flow guidance is $600M.
Bullish
Cooper Companies reported strong revenue and GAAP EPS growth, with operating margin expansion due to disciplined execution. The company also saw continued strength in its MyDay portfolio and supported share repurchases.
Bearish
Cooper Companies' non-GAAP gross margin decreased due to tariffs, and currency impacts negatively affected reported revenue growth. The company also incurred ongoing costs related to new EU medical device regulations.